Researchers at ETH Zurich in Switzerland have developed a high-throughput screening method for anti-cancer drugs that they have called “pharmascopy”. To date, the researchers have tested the system with multiple myeloma samples, a cancer…
Continue Reading
Researchers at MIT have developed an ‘electroceutical’ capsule that is designed to be swallowed and which will deliver a small electrical current to the stomach wall. The device contains an external electrode that wraps…
Continue Reading
Researchers at MIT have developed a urine test that can distinguish between different types of cancer, and could even highlight if metastases are present. The test involves first administering nanoparticles to patients that can…
Continue Reading
By Hannah Nelson
May 09, 2023 – Northwell Health has awarded $1 million to develop two employee-driven digital health innovation projects as part of the health system’s 2023 Innovation Challenge.
Winners of the competition include team leads…
Researchers at Houston Methodist have developed an implant that can provide localized and sustained release of immunotherapies to treat pancreatic cancer. Their device is tiny, at approximately the size of a grain of rice,…
Continue Reading
Oncology Ventures met with more than 250 early-stage cancer startups in the past four months. On Wednesday, the New York City-based investment fund announced the three that stood out as deserving of its capital.
The…
What You Should Know:Flatiron Health announced a new partnership today with Sanofi in their pursuit to redesign the clinical trial experience for sponsors, sites, and patients in the therapeutic area of oncology. The multi-study partnership between Sanofi and…
Continue Reading
Christine Swisher, PhD is chief scientific officer of Project Ronin of San Mateo, CA.
Tell me about yourself and the company.
My background is in healthcare, mostly in oncology, but…
Haystack Oncology was founded to dramatically improve patient outcomes with transformative precision oncology.What You Should Know:Quest Diagnostics has reached an agreement to acquire Haystack Oncology an early-stage oncology company focused on minimal residual disease (MRD) testing to aid…
Continue Reading
CHICAGO — Implementing precision medicine programs could allow health systems to diagnose disease more quickly or predict a patient’s response to a specific mediation, said panelists at the 2023 HIMSS Global Health Conference &…
Continue Reading
